OUTCOME OF 33RD ANNUAL GENERAL MEETING

| BEQHL DRUGS LIMITED Regd. Off.: 29, Neer Nagar, "Mayank Water Park Road", Bicholi Hapsi, INDORE-452016 (M.P.) INDIA Tel. : (0731) 2517677 | E-mail : beryldrugs25@yahoo.com | CIN : L02423MP1993PLC007840 ee T e s S SR R Date: 29.09.2026 DCS-Listing The Bombay Stock Exchange Limited, Phiroze JeeJeebhoy Towers, Dalal Street, Mumbai- 400001 Script code: 524606 Sub: Outcome of 33" Annual General Meeting Sir/ Madam, This is to inform you that member of Beryl Drugs Limited in its duly called and convened 33 Annual General Meeting held on Tuesday, the 29 day of September, 2026 at 11:00 A.M and concluded at 11:30 A.M at Kanchan Palace, Community Hall, Nipania Ring Road, Indore- 452001 transacted the following business with requisite majority: 1. Considered and adopted the audited financial statements of the Company for the Financial Year ended 31% March, 2026 containing the Balance Sheet as at 31st March, 2026, the Statement of Profit & Loss and Cash Flow for the year ended 31 March, 2026 and the reports of the Board of Directors and Auditors thereon. 2. Considered and approved the matter of Reappointment of the retiring Director Mr. Sudhir Sethi (DIN: 00090172). 3. Considered and approved the increase in the limit of material related party transactions with m/s. Aminova infusions pvt. Ltd. The Annual General Meeting of the Company commenced at 11:00 A.M and concluded at 11:30 A.M Please take the same on your record Thanking You, For Beryl Drugs Limited Sudhir Sethi Chairman& Direct DIN: 00090172